Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
254-284
Author(s):
G. K. Lloyd, M. A. Palladino, A. Younes, E. Valashi, M. A. Spear, C. M. Sloss, A. M. Roccaro, P. G. Richardson, F. Pajonk, H. Ovaa, Y. Oki, S. T.C. Neuteboom, C. P. Miller, D. J. McConkey, W. McBride, B. C. Potts, K. S. Lam, P. R. Jensen, M. Groll, I. M. Ghobrial, W. Fenical, J. C. Cusack, D. Chauhan, J. Chandra, B. Bonavida, C. Berkers, S. Baritaki, K. C. Anderson and M. X. Albitar
Harnessing Impaired Energy Metabolism in Cancer Cell: Small Molecule- Mediated Ways to Regulate Tumorigenesis
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
11
Page:
272-279
Author(s):
Govardhan K. Shroff, Ramyasri Kuna, Kethora Dirsipam, Ravishekar Yalagala and Prasenjit Mitra
Radioimmunotherapy of Solid Tumors: Searching for the Right Target
Journal:
Current Drug Delivery
Volume:
8
Page:
26-44
Author(s):
Hong Song and George Sgouros
Delivery of Intracellular-Acting Biologics in Pro-Apoptotic Therapies
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
293-319
Author(s):
Hongmei Li, Chris E. Nelson, Brian C. Evans and Craig L. Duvall
VEGF and HIF in Renal Cell Carcinogenesis
Journal:
Recent Patents on Biomarkers
Volume:
1
Page:
60-67
Author(s):
Minardi Daniele, Lucarini Guendalina, d' Anzeo Gianluca, Conti Alessandro, Di Primio Roberto, Montironi Rodolfo and Muzzonigro Giovanni
Angiogenesis Inhibitors: Implications for Combination with Conventional Therapies
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
3921-3931
Author(s):
Michele Moschetta, Marta Cesca, Francesca Pretto and Raffaella Giavazzi
Do Not Say Ever Never More: The Ins and Outs of Antiangiogenic Therapies
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
3932-3957
Author(s):
Ana R. Quesada, Miguel Angel Medina, Ramon Munoz-Chapuli and Angel Luis G. Ponce
Focal Adhesion Kinase as a Cancer Therapy Target
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
10
Page:
735-741
Author(s):
Vita M. Golubovskaya
Histone Deacetylases: Anti-Angiogenic Targets in Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
898-913
Author(s):
D. Mottet and V. Castronovo
PI3K/Akt/mTOR Pathway Inhibitors in Cancer: A Perspective on Clinical Progress
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
4326-4341
Author(s):
P. Wu and Y.-Z. Hu